SBRA — SABRA HEALTH CARE REIT INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About SABRA HEALTH CARE REIT INC (SBRA)
SABRA HEALTH CARE REIT INC (SBRA) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $51M. All data sourced from SEC 13F filings.
Based on recent institutional activity in SBRA
No recent activity recorded.
How many top investors track SBRA
A small number of top investors own this.
SBRA Ownership Composition
How SABRA HEALTH CARE REIT INC is held across tracked investor types, based on reported 13F positions.
- Other80.7%
- Hedge Funds19.3%
Tracked investors reporting SBRA
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.6MValue$30.5M% Portfolio0.01%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares704.1KValue$13.5M% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares560.2KValue$10.8M% Portfolio0.01%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares54KValue$1M% Portfolio0.00%
Recent activity
- No recent activity.
Frequently asked questions
- How many institutional investors hold SBRA?
- 4 tracked institutional investors disclosed a position in SBRA (SABRA HEALTH CARE REIT INC) in their most recent 13F filing.
- Who is the largest institutional holder of SBRA?
- Izzy Englander, Millennium Management, holds the largest disclosed position in SBRA, valued at $51M.
- Did institutional ownership of SBRA increase or decrease?
- Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited SBRA.
- Where does this SBRA ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.